Franco Bassani

Antinociceptive Activity of the N-Methyl-d-aspartate Receptor Antagonist N-(2-Indanyl)-glycinamide Hydrochloride (CHF3381) in Experimental Models of Inflammatory and Neuropathic Pain

Gino Villetti, M. A. C. M. Bergamaschi, Franco Bassani et al. · Journal of Pharmacology and Experimental Therapeutics · 2003 · 78 citations

CHF6001 II: A Novel Phosphodiesterase 4 Inhibitor, Suitable for Topical Pulmonary Administration—In Vivo Preclinical Pharmacology Profile Defines a Potent Anti-Inflammatory Compound with a Wide Therapeutic Window

Gino Villetti, Chiara Carnini, Loredana Battipaglia et al. · Journal of Pharmacology and Experimental Therapeutics · 2015 · 49 citations · Full text

Novel Class of Benzoic Acid Ester Derivatives as Potent PDE4 Inhibitors for Inhaled Administration in the Treatment of Respiratory Diseases

Elisabetta Armani, Gabriele Amari, Andrea Rizzi et al. · Journal of Medicinal Chemistry · 2014 · 47 citations · Full text

Asthma, Pharmaceutical Science, Inflammatory Lung Disease +19

Pharmacological assessment of the duration of action of glycopyrrolate vs tiotropium and ipratropium in guinea‐pig and human airways

Gino Villetti, M. A. C. M. Bergamaschi, Franco Bassani et al. · British Journal of Pharmacology · 2006 · 43 citations · Full text

Asthma, Molecular Pharmacology, Human Airways +14

Preclinical Evaluation of CHF3381 as a Novel Antiepileptic Agent

Gino Villetti, Gianni Bregola, Franco Bassani et al. · Neuropharmacology · 2001 · 42 citations

Novel Antiepileptic Agent, Medicine, Clinical Pharmacology +3